# HELIX GUARD — TASK 8.2 FINAL ACCEPTANCE REPORT

**Document ID**: `TASK_8_2_FINAL_ACCEPTANCE_REPORT`  
**Execution Timestamp**: 2026-11-04T13:50:00+05:30  
**Repository**: `https://github.com/mukunda7777777/Project-Helix_Guard`  
**Milestone**: Task 8.2 — Live Multi-Source Variant Verification & Clinical Evidence Validation  
**Final Status**: **ACCEPTED & VERIFIED (PASS)**  
**Regression Test Baseline**: **128 / 128 Passed (0 Failures, 0 Skips, 100% Pass Rate)**  

---

## 1. Executive Summary & Acceptance Decision

Task 8.2 extends the variant-level evidence intelligence architecture created in Task 8.1 by subjecting all source adapters, aggregation mechanisms, failure handling pathways, and user-facing workflows to rigorous live empirical testing, correctness verification, and end-to-end application integration.

Across three sequential execution phases:
1. **Phase 1 (Live Empirical Audit)**: Executed controlled network queries for 5 canonical benchmark variants across 5 external biological sources (25 query combinations) with strict timeouts and zero rate-limiting stalls.
2. **Phase 2 (Evidence Correctness Validation)**: Reconciled raw network responses against curated benchmarks, investigated gnomAD v4 indel syntax boundaries, eliminated duplicate PubMed publications, and guaranteed live vs. local-reference isolation.
3. **Phase 3 (Application Integration & Regression)**: Validated end-to-end user workflows in the Streamlit application via `AppTest`, verified daemon stability (`/_stcore/health` HTTP 200), tested comprehensive failure recovery (timeouts, 429, 500, unindexed loci), resolved ClinVar modern schema parsing, and confirmed 128/128 passing regression tests.

**Formal Acceptance Decision**: **PASS**. Task 8.2 is marked **COMPLETE** in its entirety.

---

## 2. Phase Summaries

### Phase 1: Live Empirical Audit Summary
- Conducted 25 controlled external queries across NCBI ClinVar, Ensembl VEP, gnomAD v4, NCBI PubMed, and ClinGen.
- Captured complete raw network payloads into `task_8_2_phase1_live_audit_raw.json`.
- Established that remote APIs are functional, but exhibit varying latency and availability:
  - NCBI ClinVar: High availability, latency 5.7s – 18.2s.
  - Ensembl VEP: Functional for SNVs and indels, but prone to upstream rate-limiting or latency >25s.
  - gnomAD v4: Ultra-fast (5s) GraphQL execution for canonical nucleotide SNVs; returned null for non-VCF alleles (`dup`, `-`).
  - NCBI PubMed: Fast E-utilities responses (<2s) returning verified biomedical citations.
  - ClinGen: High-confidence expert gene-disease validity curations.
- Enforced strict epistemological isolation: Unobserved or timed-out queries were never fabricated as confirmed negatives ($AF = 0$).

### Phase 2: Evidence Correctness Validation Summary
- Audited 100% of Phase 1 raw payloads against parsed contracts.
- Discovered that gnomAD v4 GraphQL requires minimally left-aligned `<chr>-<pos>-<ref>-<alt>` nucleotide syntax (`[ACGT]+`). Added `is_vcf_format` guard in `GnomadAdapter` to bypass malformed remote calls for non-nucleotide alleles.
- Verified that ClinVar conflicting submissions (e.g. `rs1042522` *TP53* P72R and `rs28897724` *BRCA1* R1699Q) remain explicitly marked as conflicting (`is_conflicting=True`), preserving submitter disagreements without artificial flattening.
- Identified and eliminated duplicate PubMed citations by PMID in `PubMedAdapter._parse_pubmed_summaries`.
- Added 3 focused regression tests in `test_evidence_engine.py`, bringing the test suite to 128 passing tests.

### Phase 3: Application Integration & Daemon Verification Summary
- Verified the complete evidence workflow through the actual application interface.
- Demonstrated end-to-end variant lookup, transcript consequence inspection, population constraint analysis, literature citation review, and multi-source status display for all five benchmark variants.
- Verified failure resilience under simulated API timeouts, HTTP 429 throttling, HTTP 500 server errors, and unindexed variants.
- Resolved NCBI ClinVar modern schema migration defect where primary classification was moved into `germline_classification`.
- Launched real Streamlit server daemon on port 8503, verified health probe (`HTTP 200`), verified main app page (`HTTP 200`), and terminated process cleanly.

---

## 3. Five-Variant Verification Matrix

| Variant ID | Gene | Benchmark Title | Normalized Locus (GRCh38) | Primary Clinical Classification | gnomAD v4 Allele Frequency | Transcripts Retrieved | Citations (PMIDs) | End-to-End Status |
|---|---|---|---|---|---|---|---|---|
| **`rs28897743`** | *BRCA1* | c.5266dupC (5382insC) | `chr17:43044295 C>dup` | Pathogenic (2★, Concordant) | $AF = 0.000151$ (Local Reference Snapshot) | 42 Transcripts | 1 PMID (Unique) | **VERIFIED** |
| **`rs121913527`** | *TP53* | c.743G>A (p.Arg248Gln) | `chr17:7674220 C>T` | Pathogenic/Likely pathogenic (2★) | Live $AF = 6.16 \times 10^{-6}$ ($AC=9, AN=1.46\times 10^6$) | 39 Transcripts | 1 PMID (Unique) | **VERIFIED** |
| **`rs1042522`** | *TP53* | c.215C>G (p.Pro72Arg) | `chr17:7676154 G>C` | Likely benign / Conflicting (3★) | Live $AF = 0.7163$ ($AC=1.05\times 10^6$, Common Polymorphism) | 1 Transcript | 5 PMIDs (Deduplicated) | **VERIFIED** |
| **`rs28897724`** | *BRCA1* | c.5095C>T (p.Arg1699Gln) | `chr17:43057110 C>T` | Conflicting interpretations (1★, Discordant) | $AF = 3.18 \times 10^{-5}$ (Local Reference Snapshot) | 1 Transcript | 1 PMID (Unique) | **VERIFIED** |
| **`rs80357906`** | *BRCA1* | c.68_69delAG (185delAG) | `chr17:43124031 AG>-` | Pathogenic (2★, Concordant) | $AF = 9.55 \times 10^{-5}$ (Local Reference Snapshot) | 70 Transcripts | 5 PMIDs (Deduplicated) | **VERIFIED** |

---

## 4. Five-Source Evidence Matrix

| Evidence Source | Primary Role | Live Capability Verified | Fallback Mechanism Verified | Provenance Badge |
|---|---|---|---|---|
| **NCBI ClinVar** | Clinical classification, ACMG review status, submitter concordance | E-utilities live search + esummary retrieval (Supports modern `germline_classification`) | Curated benchmark snapshot with submitter assertions | `🟢 Live Request` / `🔵 Validated Cache` / `🟣 Local Reference Snapshot` |
| **Ensembl VEP** | Transcript consequences, SIFT & PolyPhen scores, MANE select | Region REST query (`/vep/homo_sapiens/region/...`) | Curated transcript consequence suite | `🟢 Live Request` / `🔵 Validated Cache` / `🟣 Local Reference Snapshot` |
| **gnomAD v4** | Global population allele frequencies, $AC$, $AN$, homozygotes | GraphQL v4 query (`https://gnomad.broadinstitute.org/api`) | Curated global & subpopulation frequency records | `🟢 Live Request` / `🔵 Validated Cache` / `🟣 Local Reference Snapshot` |
| **NCBI PubMed** | Primary scientific literature, variant-specific functional citations | E-utilities esearch + esummary with PMID deduplication | Curated milestone papers | `🟢 Live Request` / `🔵 Validated Cache` / `🟣 Local Reference Snapshot` |
| **ClinGen** | Expert gene-disease validity, dosage sensitivity | Gene-level consensus evaluation | Expert panel curated baseline | `🟢 Live Request` / `🔵 Validated Cache` / `🟣 Local Reference Snapshot` |

---

## 5. Defect Register & Applied Remediations

| Defect ID | Severity | Module | Description | Root Cause | Fix Applied | Status |
|---|---|---|---|---|---|---|
| **DEF-8.2-01** | Medium | `PubMedAdapter` | Potential duplicate citations when summary UIDs repeat. | PubMed E-utilities returned duplicate IDs across summary chunks. | Added PMID deduplication check in `_parse_pubmed_summaries`. | **FIXED** |
| **DEF-8.2-02** | Medium | `GnomadAdapter` | Malformed GraphQL queries for non-VCF alleles (`dup`, `-`). | gnomAD v4 GraphQL variant endpoint requires strict `[ACGT]+` nucleotides. | Added `is_vcf_format` check; non-VCF alleles engage verified fallback snapshot directly. | **FIXED** |
| **DEF-8.2-03** | Low | `live_variant_audit.py` | Audit script attribute lookup error on ClinicalClassification. | Property named `primary_classification`, not `clinical_significance`. | Corrected property access in audit runner. | **FIXED** |
| **DEF-8.2-04** | High | `ClinVarAdapter` | Modern ClinVar live records returned `Unknown (0 stars)`. | NCBI moved top-level clinical classification to `germline_classification`. | Updated `_parse_clinvar_summary_dict` to check `germline_classification` or `clinical_significance`. | **FIXED** |
| **DEF-8.2-05** | Medium | `tests/test_evidence_engine.py` | Offline fallback test failed when previous live queries left cache files. | Test omitted `use_cache=False` when verifying offline mock timeout. | Added explicit `use_cache=False` to `test_ensembl_adapter_variant_consequences_parsing`. | **FIXED** |

---

## 6. Complete Regression Test Suite Results

```text
============================= test session starts =============================
platform win32 -- Python 3.10.11, pytest-8.3.4
rootdir: P:\projects\HELIX GUARD-20260822T181751Z-1-001\HELIX GUARD
collected 128 items

tests/test_evidence_engine.py ................................................... [ 39%]
tests/test_genetic_data_engine.py ......................                         [ 57%]
tests/test_quantum_engine.py ....................                                [ 72%]
tests/test_streamlit_app.py ...................................                  [100%]

============================== warnings summary ===============================
tests/test_genetic_data_engine.py: 2 warnings
tests/test_streamlit_app.py: 56 warnings
128 passed, 58 warnings in 169.01s (0:02:49)
Exit Code: 0
```

- **All 128 tests pass unconditionally**.
- Zero failed tests, zero skipped tests, zero xfailed tests.
- Execution time: 169.01s.

---

## 7. Known Environmental & Scientific Limitations

1. **Upstream Network Latency**: Remote public APIs (NCBI Entrez, Ensembl REST, Broad gnomAD) occasionally enforce IP-level rate limits or experience transient latencies exceeding 20 seconds. The orchestrator's timeout management and offline reference snapshots ensure seamless research continuity.
2. **gnomAD v4 Indel Left-Alignment**: gnomAD v4 indexes indels strictly by minimal left-aligned coordinates. Input formats using HGVS duplication syntax (`c.5266dupC`) or deletion strings (`185delAG`) return `null` from the live GraphQL API and correctly activate the local reference snapshot. Full automatic left-alignment normalization can be expanded in subsequent data pipeline tasks.
3. **Research-Only Epistemological Boundary**:
   - Submitter disagreement is not proof of pathogenicity.
   - Population rarity is not proof of disease causation.
   - High population frequency does not rule out low-penetrance or adult-onset disease.
   - In-silico predictions (SIFT, PolyPhen, QNN, CNN) are hypothesis-generating computational models, not diagnostic truths.

---

## 8. Final Acceptance Sign-off

| Acceptance Criterion | Verification Method | Result | Sign-off |
|---|---|---|---|
| Phase 1 Documented & Persisted | Raw JSON and markdown report in `docs/` | Complete (`TASK_8_2_PHASE_1_LIVE_AUDIT_REPORT.md`) | **PASSED** |
| Phase 2 Documented & Persisted | Validation report & defect register in `docs/` | Complete (`TASK_8_2_PHASE_2_VALIDATION_REPORT.md`) | **PASSED** |
| Phase 3 Integration & UI Verified | Full `AppTest` + Daemon health check | Complete (`TASK_8_2_PHASE_3_INTEGRATION_REPORT.md`) | **PASSED** |
| 5 Canonical Benchmark Traceability | All 5 variants tested with traceable outcomes | Complete (100% matched) | **PASSED** |
| Provenance & Live/Local Distinction | `is_local_reference` enforced across contracts | Complete (Zero conflation) | **PASSED** |
| Failure & Recovery Resilience | Mocked timeout, 429, 500, unindexed loci | Complete (Zero silent corruption) | **PASSED** |
| Zero Unresolved Critical Defects | Defect register verified and tested | Complete (All 5 defects fixed) | **PASSED** |
| Full Regression Suite Passing | `pytest tests/` | Complete (128/128 passed) | **PASSED** |

**Final Recommendation**: Proceed directly to **Task 8.3 (Variant Evidence Visualization & Deep UI Polish)** on the Helix Guard project roadmap.
